Primary and secondary infections by human parvovirus B19 following bone marrow transplantation: Characterization by PCR and B-cell molecular immunology

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 2, 1997, Pages 129-135

  Söderlund, Maria ^a,c   Ruutu, Petri ^b   Ruutu, Tapani ^b   Asikainen, Kari ^a   Franssila, Rauli ^a   Hedman, Klaus ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ANEMIA; ARTHRITIS; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CASE REPORT; DISEASE SEVERITY; ERYTHEMA INFECTIOSUM; ERYTHROCYTE; FEMALE; FETUS DEATH; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOLOGY; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; STEM CELL; SUPERINFECTION; THROMBOCYTOPENIA; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0030905624     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709035872     Document Type: Article

References (37)

1. Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transpl 5: 209-226, 1990.
2. Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny. Bone Marrow Transpl 12: 387-398, 1993.
3. Anderson MJ, Lewis E, Kidd IM, Hall SM, Cohen BJ. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Camb) 93: 85-93, 1984.
4. Bartolomei Corsi O, Azzi A, Morfini M, Fanci R, Rossi-Ferrini P. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 25: 165-170, 1988.
5. Young N, Harrison M, Moore J, Mortimer P, Humphries RK. Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro. J Clin Invest 74: 2024-2032, 1984.
6. Pattison JR, Jones SE, Hodgson J, Davis LR, White JM, Stroud CE, Murtaza L. Parvoviral infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1: 664-665, 1981.
7. Faden H, Gary J G W., Anderson LJ. Chronic parvovirus infection in a presumably immunologically healthy woman. Clin Infect Dis 15: 595-597, 1992.
8. Murray JC, Gresik MV, Leger F, McClain KL. B19 parvovirusinduced anemia in a normal child. Initial bone marrow erythroid hyperplasia and response to intravenous immunoglobulin. Am J Pediatr Hematol Oncol 15: 420-423, 1993.
9. Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 317: 287 294, 1987.
10. Frickhofen N, Abkowitz JL, Safford M, Berry JM, Anturez-de-Mayolo J, Astrow A, Cohen R, Haperin I, King L, Mintzer D. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause of anemia in AIDS. Ann Intern Med 113: 926-933, 1990.
11. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, Pattison JR, Tyrrell DA. Experimental parvoviral infection in humans. J Infect Dis 152: 257-265, 1985.
12. Weiland HT, Salimans MMM, Fibbe WE, Kluin PM, Cohen BJ. Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant recipient. Br J Haematol 79: 300, 1989.
13. Pillay D, Patou G, Griffiths P, Rees L. Secondary parvovirus B19 infection in an immunocompromised child. Pediatr Infect Dis J 10: 623-624, 1991.
14. Bremner JAG, Beard S, Cohen BJ, Alimenti A, Cantiniaux B, Levy J. Secondary infection with parvovirus B19 in an HIV-positive patient. AIDS 7: 1131-1132, 1993.
15. Cassinotti P, Schultze D, Wieczorek K, Schönenberger R, Siegl G. Parvovirus B19 infection during pregnancy and development of hydrops fetalis despite the evidence for preexisting anti-B19 antibody: how reliable are serological results? Clin Diagnos Virol 2: 87-94, 1994.
16. Gundestrup M, Yun Z-B, Hornsleth A, Jacobsen N. High incidence of posttransplant parvovirus B19 infection in a consecutive series of 184 bone marrow allograft recipients. A probable cause of post-transplant pancytopenia. In: Quesenberry PJ, ed. Experimental Hematology. Parma, Italy: Springer International, 571, 1991.
17. Frickhofen N, Arnold R, Hertenstein B, Wiesneth M, Young NS. Parvovirus B19 infection and bone marrow transplantation. Ann Hematol 64: 121-124, 1992.
18. Söderlund M, Brown CS, Cohen BJ, Hedman K. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis 171: 710-713, 1995.
19. Söderlund M, Brown CS, Spaan WJM, Hedman L, Hedman K. Epitope type-specific IgG responses to capsid proteins VPI and VP2 of human parvovirus B19. J Infect Dis 172: 1431-1436. 1995.
20. Franssila R, Söderlund M, Brown C, Spaan W, Seppälä I. Hedman K. IgG subclass response to human parvovirus B19 infection. Clin Diagnos Virol 6: 41-49, 1996.
21. Söderlund , Brown KE, Meurman O, Hedman K. Prokaryotic expression of a VPI polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay. J Clin Microbiol 30: 305-311, 1992.
22. Brown CS, van Lent JWM, Vlak JM, Spaan WJM. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. J Virol 65: 2702-2706, 1991.
23. Cohen BJ, Mortimer PP, Pereira MS, Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg (Camb) 91: 113-130, 1983.
24. Hedman K, Lappalainen M, Söderlund M, Hedman L. Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol 4: 123-129, 1993.
25. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organization of human parvovirus B19 isolated from a child during aplastic crisis. J Virol 58: 921-936, 1986.
26. Azzi A, Fanci R, Ciappi S, Zakrzewska K, Bosi A. Human parvovirus B19 infection in bone marrow transplantation patients. Am J Hematol 44: 207-209, 1993.
27. Erdman DD, Usher MJ, Tsou C, Caul EO, Gary GW, Kajigaya S, Young NS, Anderson LJ. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol 35: 110-115, 1991.
28. Musiani M, Zerbini M, Gentilomi G, Plazzi M, Gallinella G, Venturoli S. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 172: 1360-1363, 1995.
29. Wahren B, Gahrton G, Linde A, Ljungman P, Lönnqvist B, Ringden O, Sundqvist VA. Transfer and persistence of viral antibody-producing cells in bone marrow transplantation. J Infect Dis 150: 358-365, 1984.
30. Wimperis JZ, Brenner MK, Prentice HG, Reittie JE, Karayiannis P, Griffiths PD, Hoffbrand AV. Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet i: 339-343, 1986.
31. Adler SP, Manganello A-MA, Koch WC, Hempfling SH, Best AM. Risk of human parvovirus B19 infections among school and hospital employees during endemic periods. J Infect Dis 168: 361-368, 1993.
32. Gray J, Cohen B, Desselberger U. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. J Virol Meth 44: 11-24, 1993.
33. Lutz E, Ward KN, Szydlo R, Goldman JM. Cytomegalovirus antibody avidity in allogeneic bone marrow recipients: Evidence for primary or secondary humoral responses depending on donor immune status. J Med Virol 49: 61-65, 1966.
34. Thomas HIJ, Morgan-Capner P. Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection. Epidemiol Infect 101: 591-598, 1988.
35. Enders G, Knotek F. Rubella IgG total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection. Infection 17: 218-226, 1989.
36. Hedman K, Rousseau SA. Measurement of avidity of specific IgG for verification of recent primary rubella. J Med Virol 27: 288-292, 1989.
37. Aalberse RC, van der Gaag R, van Leeuwen J. Serologic aspects of IgG4 antibodies. Prolonged immunization results in an IgG4-restricted response. J Immun 130: 722-726, 1983.